FITB:NASDAQFifth Third Bancorp Analysis
Data as of 2026-03-10 - not real-time
$46.98
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Technical outlook: The share price is trading below its short‑term moving averages yet remains above the long‑term trend, with RSI in oversold territory and a bearish MACD divergence. It sits near a key support level while a higher resistance ceiling caps immediate upside. The discounted cash‑flow valuation places intrinsic value well above the current market price, suggesting notable upside potential.
Fundamental backdrop: The bank is delivering double‑digit revenue growth, strong operating margins and a P/E multiple that trails the industry average. An attractive dividend yield combined with a payout ratio comfortably below 50% supports dividend sustainability. Analyst consensus is bullish with a “buy” rating, and a beta close to one indicates market‑aligned risk. Moderate 30‑day volatility and a U.S.‑centric footprint keep geographic and currency risks low.
Fundamental backdrop: The bank is delivering double‑digit revenue growth, strong operating margins and a P/E multiple that trails the industry average. An attractive dividend yield combined with a payout ratio comfortably below 50% supports dividend sustainability. Analyst consensus is bullish with a “buy” rating, and a beta close to one indicates market‑aligned risk. Moderate 30‑day volatility and a U.S.‑centric footprint keep geographic and currency risks low.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price near technical support
- oversold RSI indicating potential bounce
- bearish MACD suggesting caution
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- undervalued relative to DCF fair value
- solid earnings growth and margins
- attractive dividend yield with sustainable payout
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- consistent cash generation and low leverage
- stable U.S. market exposure limiting external risks
- long‑term upside from valuation gap and dividend compounding
Key Metrics & Analysis
Financial Health
Revenue Growth11.60%
Profit Margin30.19%
P/E Ratio13.3
ROE12.19%
ROA1.18%
P/B Ratio1.6
Op. Cash Flow$4.5B
Industry P/E17.4
Technical Analysis
TrendBullish
RSI33.1
Support$45.26
Resistance$55.44
MA 20$51.41
MA 50$50.56
MA 200$44.81
MACDBearish
VolumeStable
Fear & Greed Index79.68
Valuation
Fair Value$67.06
Target Price$57.68
Upside/Downside22.77%
GradeUndervalued
TypeBlend
Dividend Yield3.41%
Risk Assessment
Beta1.04
Volatility32.32%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.